Lenz & Staehelin advised the selling shareholders in this transaction. Freshfields Bruckhaus Deringer LLP and Bär & Karrer advised ZAPI Group on the deal. Forestay Capital...
Zapi Group’s Acquisition of BlueBotics
Essential Pharma’s Acquisition of Ocular And Postpartum Therapies From Novartis
Lenz & Staehelin advised Essential Pharma in this transaction. Essential Pharma, a portfolio company of Gyrus Capital, has acquired on December 8, 2021, the worldwide rights...
Carlyle’s Acquisition of AutoForm From Astorg
Lenz & Staehelin advised Carlyle in this transaction, alongside Linklaters and Latham & Watkins. Paul Hastings advised Astorg. Jeausserand Audouard advised the management of AutoForm. The...
Transmutex’s CHF 5.3 Million Series A Financing Round
Lenz & Staehelin advised Transmutex on the deal. The Geneva based cleantech company Transmutex has completed its CHF 5.3 million Series A. This comes a couple...
Félix Badel & Cie SA’s Competition Commission Investigation on Electricity Companies in Geneva Close
Lenz & Staehelin represented Félix Badel & Cie SA in the deal. Félix Badel & Cie SA, the Electrical installation company, has been involved in the Competition Commission...





























